Drilling activity is already increasing in the U.S. – here’s what investors need to know.

Beaten-up biotech has some work to do to restore investor confidence. Here's how Gilead Sciences, Valeant Pharmaceuticals, and the entire industry can get back on track in 2017.

Grab your popcorn and have a seat as we look back at the record-setting slate of movie releases from last year, the leading entertainment companies behind them, and what film-loving investors can expect in 2017.

The IF crew is looking back at some of their favorite episodes of 2016 . . .

Companies love to include equity grants in employee compensation, but how does it impact investors?

The IF crew is looking back at some of their favorite episodes of 2016 . . .

Oil Producers have business models that make them unique on Wall Street, here's what you need to know.